Assessing the downstream value of first-line cardiac positron emission tomography (PET) imaging using real world Medicare fee-for-service claims data
ConclusionsFirst-line PET imaging was not associated with reduced levels of utilization and spending. Clinical outcomes were mostly similar.
Source: Journal of Nuclear Cardiology - Category: Nuclear Medicine Source Type: research
More News: Angioplasty | Cardiology | Coronary Angioplasty | CT Scan | Heart | Medicare | Nuclear Medicine | Percutaneous Coronary Intervention | PET Scan | SPECT | Study